Home LiteratureArticle Details
PMID: 1928158 Published · ppublish English Journal Article

Striving for benchmark infection rates: progress in control for patient mix.

The American journal of medicine ·Vol. 91 ·No. 3B ·1991-09-16 ·Pages 16S-20S

Gross PA

Abstract

The outcome of clinical events has become the major focus for quality assurance programs in the United States. Assessment of outcome depends on the availability of accurate benchmark rates appropriate to the clinical situation. Although mortality, length of stay, cost, and other resource utilization measures are important outcome events for review, nosocomial infection is one of the best-studied outcome events for which benchmark rates and distributions of rates are available. To monitor nosocomial infection acquisition, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) has proposed indicators for wound infections after clean and clean-contaminated surgical procedures, for pneumonia in intensive care units (ICUs), and for intravascular device infections in ICUs. From the National Nosocomial Infections Surveillance (NNIS) system, we know that the mean rate of surgical wound infections (SWIs) for clean-contaminated wounds is 2.7%. However, the range is too broad and depends on the types of surgical procedures and the patient risk factors in each category. As an example, the SWI rate for appendectomies is 2.2% while for colon surgery it is 7.1%. In addition, the patients should be stratified by underlying risk factors. For example, the NNIS risk index is composed of wound class, duration of surgery, and American Society of Anesthesiology score. Other commonly used severity of illness scores could be used, such as a comorbidity score or APACHE II. Other proposed JCAHO indicators are reviewed. Controlling for case mix and for severity of illness will be necessary for the development of benchmark infection rate distributions if clinical indicators are to be used as reliable quality assurance tools in the 1990s.

MeSH Terms
Anti-Bacterial Agents/therapeutic use Catheterization/adverse effects Cross Infection/epidemiology,prevention & control Diagnosis-Related Groups Humans Outcome and Process Assessment, Health Care Pneumonia/epidemiology Quality Assurance, Health Care Severity of Illness Index Surgical Wound Infection/epidemiology,microbiology
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Gross P A
Department of Internal Medicine, Hackensack Medical Center, New Jersey 07601.
Article Info
Journal
The American journal of medicine
Abbr.
Am J Med
ISSN
0002-9343
Published
1991-09-16
Pages
16S-20S
Language
English
Region
United States
NLM ID
0267200
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]